Bicocca Open Archive

Logo unimib boa
MEREGALLI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.080
AS - Asia 16.741
EU - Europa 9.017
SA - Sud America 1.680
AF - Africa 317
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 21
Totale 46.930
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.030
VN - Vietnam 4.938
SG - Singapore 4.898
CN - Cina 2.869
IT - Italia 1.851
HK - Hong Kong 1.575
RU - Federazione Russa 1.421
DE - Germania 1.376
BR - Brasile 1.237
SE - Svezia 949
CA - Canada 866
IE - Irlanda 710
GB - Regno Unito 566
UA - Ucraina 514
IN - India 466
FR - Francia 452
KR - Corea 395
ID - Indonesia 253
FI - Finlandia 243
BD - Bangladesh 228
JP - Giappone 182
TR - Turchia 178
AR - Argentina 168
AT - Austria 160
NL - Olanda 138
IQ - Iraq 128
ES - Italia 113
MX - Messico 112
ZA - Sudafrica 108
PL - Polonia 96
LT - Lituania 88
DK - Danimarca 87
PK - Pakistan 84
CH - Svizzera 70
SA - Arabia Saudita 63
BE - Belgio 61
EC - Ecuador 58
AU - Australia 57
CO - Colombia 56
PH - Filippine 56
VE - Venezuela 54
IR - Iran 51
TW - Taiwan 51
EG - Egitto 40
UZ - Uzbekistan 35
MY - Malesia 34
MA - Marocco 32
CL - Cile 31
PY - Paraguay 30
TN - Tunisia 29
KE - Kenya 27
AE - Emirati Arabi Uniti 26
ET - Etiopia 26
JO - Giordania 26
TH - Thailandia 26
KZ - Kazakistan 25
IL - Israele 24
NP - Nepal 21
OM - Oman 19
RO - Romania 19
EU - Europa 18
AZ - Azerbaigian 17
NZ - Nuova Zelanda 16
BG - Bulgaria 15
BO - Bolivia 15
PE - Perù 15
UY - Uruguay 14
CZ - Repubblica Ceca 13
JM - Giamaica 12
GR - Grecia 11
PS - Palestinian Territory 11
AL - Albania 10
CR - Costa Rica 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
BH - Bahrain 9
HN - Honduras 9
PA - Panama 9
KG - Kirghizistan 8
RS - Serbia 8
NG - Nigeria 7
NO - Norvegia 7
AO - Angola 6
MD - Moldavia 6
NI - Nicaragua 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
SK - Slovacchia (Repubblica Slovacca) 5
KH - Cambogia 4
KW - Kuwait 4
LB - Libano 4
LV - Lettonia 4
MM - Myanmar 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CY - Cipro 3
EE - Estonia 3
Totale 46.858
Salva come PNG Salva come JPEG
Città #
Singapore 3.060
Ann Arbor 2.832
Dallas 1.774
Ho Chi Minh City 1.540
Ashburn 1.523
Hong Kong 1.479
San Jose 1.256
Hanoi 1.182
Frankfurt am Main 703
Milan 692
Dublin 687
Chandler 666
Woodbridge 649
Toronto 594
Wilmington 537
New York 512
Jacksonville 464
Los Angeles 459
Dearborn 453
Houston 448
Beijing 420
Fairfield 405
Santa Clara 374
Chicago 292
Council Bluffs 292
Hefei 289
Seoul 282
Princeton 271
The Dalles 239
Nanjing 200
Seattle 195
Boardman 185
Jakarta 178
Shanghai 165
Buffalo 160
Lauterbourg 155
Haiphong 137
Da Nang 135
Cambridge 126
Moscow 125
Vienna 125
São Paulo 119
Ha Long 118
Munich 109
Orem 108
Guangzhou 105
Hải Dương 103
Helsinki 102
Tokyo 98
Biên Hòa 82
Quận Bình Thạnh 81
Dong Ket 74
Lachine 74
Chennai 73
London 69
Lawrence 67
Nanchang 67
Thái Nguyên 67
Vilnius 67
Ninh Bình 66
Can Tho 65
Rome 64
Montreal 63
Bắc Ninh 62
Altamura 61
Vũng Tàu 61
Warsaw 59
Nuremberg 58
Shenyang 56
Atlanta 55
Denver 54
Amsterdam 53
Zurich 53
Baghdad 51
Brooklyn 51
Bắc Giang 51
Johannesburg 51
Phoenix 50
Andover 49
Stockholm 48
Jinan 47
Pune 46
Tianjin 45
Poplar 44
Fremont 43
Quận Một 43
Quận Phú Nhuận 42
Rio de Janeiro 42
Turku 42
Changsha 40
Zhengzhou 40
Brussels 39
Basingstoke 38
Hangzhou 37
Phủ Lý 37
Quận Sáu 37
San Diego 37
Baltimore 36
Boston 36
Kent 36
Totale 29.831
Salva come PNG Salva come JPEG
Nome #
Role of ER-mitochondria interaction in the mechanism of chemotherapy-induced peripheral neuropathy 752
Paclitaxel acutely activates ICRAC in sensory neurons: implications for paclitaxel-induced peripheral neuropathy 624
CIPN and its mechanism of development 609
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 576
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 540
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 502
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 501
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 492
Bortezomib-induced peripheral neuropathy: an up-close look at endoplasmic reticulum-mitochondria interaction 485
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 484
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 447
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 442
Paclitaxel activates SOCE/ICRAC in dorsal root ganglion neurons: implications for paclitaxel-induced peripheral neuropathy 433
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 425
Age-related changes in the function and structure of the peripheral sensory pathway in mice 420
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 420
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 415
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 410
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 404
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 397
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 396
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 387
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 386
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 380
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 379
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 373
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 369
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 366
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 354
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 351
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 349
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 346
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 345
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 342
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 342
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 338
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 333
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 330
Chemotherapy-induced peripheral neuropathy: a focus on ER-mitochondrial interactions 326
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 322
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 316
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 316
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 312
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 312
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 311
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 304
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 303
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 302
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 302
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 302
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 301
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 299
Chemotherapy-induced peripheral neuropathy: a focus on mitochondria and ER- MITOCHONDRIA INTERACTIONS 299
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 298
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 296
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 296
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 291
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 291
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 290
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 289
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 289
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 289
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 287
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 284
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 284
In vivo study of Carfilzomib-Induced Neuropathy 280
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 279
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 277
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 276
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 273
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 270
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 270
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 270
Multimodal experimental approach to the study of human neurological diseases 266
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 263
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 260
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 259
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 258
MSCs effect on Dark Agouti rats affected by chronic EAE 256
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 255
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 251
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 251
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 250
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 249
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 249
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 248
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 246
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 245
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 245
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 244
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 244
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 243
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 243
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 242
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 241
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 240
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 238
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 238
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 234
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 234
Totale 33.242
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.566
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021547 0 0 0 0 0 0 0 0 0 0 220 327
2021/20221.905 161 214 167 180 142 174 84 99 67 121 143 353
2022/20232.991 376 737 335 270 222 486 42 144 223 43 76 37
2023/20242.539 83 65 69 89 329 590 408 114 148 53 45 546
2024/20258.062 422 859 661 432 651 380 511 283 935 1.083 704 1.141
2025/202623.134 4.591 2.438 2.639 1.817 1.958 1.178 2.865 1.117 1.676 1.753 1.102 0
Totale 48.329